HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabapentin decreases the severity of dystonia at low doses in a genetic animal model of paroxysmal dystonic choreoathetosis.

Abstract
The effects of the gamma-aminobutyric acid (GABA)-potentiating drug gabapentin (1-(aminomethyl) cyclohexaneacetic acid) on severity of dystonia were examined in a hamster model of idiopathic paroxysmal dystonic choreoathetosis. In the genetically dystonic hamster (dt(sz)) recent pharmacological and neurochemical studies suggested that disturbed GABAergic inhibition is involved in the pathogenesis. In line with a case report of beneficial effects in human paroxysmal dystonic choreoathetosis, gabapentin reduced the severity of dystonia in mutant hamsters at doses of 5 and 10 mg kg(-1) i.p. At higher doses (20 and 100 mg kg(-1)), gabapentin, however, failed to exert antidystonic effects. The GABApotentiating activity of gabapentin could explain the antidystonic effects of low doses, while the loss of efficacy at higher doses may be due to other mechanisms of gabapentin.
AuthorsA Richter, W Löscher
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 369 Issue 3 Pg. 335-8 (Mar 26 1999) ISSN: 0014-2999 [Print] Netherlands
PMID10225372 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetates
  • Amines
  • Anticonvulsants
  • Cyclohexanecarboxylic Acids
  • Excitatory Amino Acid Antagonists
  • gamma-Aminobutyric Acid
  • Gabapentin
Topics
  • Acetates (therapeutic use)
  • Amines
  • Animals
  • Anticonvulsants (therapeutic use)
  • Cricetinae
  • Cyclohexanecarboxylic Acids
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Dystonia (drug therapy, genetics)
  • Excitatory Amino Acid Antagonists (therapeutic use)
  • Gabapentin
  • gamma-Aminobutyric Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: